RTW Biotech Opportunities Ltd announces that Boston Scientific Corporation has agreed to acquire Penumbra, Inc., a public portfolio company, in a transaction valued at $14.5 billion...
RTW Biotech Opportunities Ltd announces that Boston Scientific Corporation has agreed to acquire Penumbra, Inc., a public portfolio company, in a transaction valued at $14.5 billion...